BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn’s disease. Am J Gastroenterol. 2009;104:1723-1733. [PMID: 19455129 DOI: 10.1038/ajg.2009.184] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Sánchez-muñoz F, Fonseca-camarillo GC, Villeda-ramirez MA, Barreto-zuniga R, Bojalil R, Domínguez-lopez A, Uribe M, Yamamoto-furusho JK. TLR9 mRNA expression is upregulated in patients with active ulcerative colitis: . Inflammatory Bowel Diseases 2010;16:1267-8. [DOI: 10.1002/ibd.21155] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
2 Fiocchi C. Genes and 'in-vironment': how will our concepts on the pathophysiology of inflammatory bowel disease develop in the future? Dig Dis. 2012;30 Suppl 3:2-11. [PMID: 23295686 DOI: 10.1159/000342585] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
3 Husmann CA, Holle JU, Moosig F, Mueller S, Wilde B, Cohen Tervaert JW, Harper L, Assmann G, Gross WL, Epplen JT, Wieczorek S. Genetics of toll like receptor 9 in ANCA associated vasculitides. Ann Rheum Dis 2014;73:890-6. [PMID: 23592712 DOI: 10.1136/annrheumdis-2012-202803] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
4 Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F, Cianci R. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology. J Immunol Res. 2015;2015:489821. [PMID: 26090491 DOI: 10.1155/2015/489821] [Cited by in Crossref: 107] [Cited by in F6Publishing: 98] [Article Influence: 15.3] [Reference Citation Analysis]
5 Fukata M, Vamadevan AS, Abreu MT. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin Immunol. 2009;21:242-253. [PMID: 19748439 DOI: 10.1016/j.smim.2009.06.005] [Cited by in Crossref: 208] [Cited by in F6Publishing: 186] [Article Influence: 16.0] [Reference Citation Analysis]
6 Su SL, Yang HY, Lee CH, Huang GS, Salter DM, Lee HS. The (-1486T/C) promoter polymorphism of the TLR-9 gene is associated with end-stage knee osteoarthritis in a Chinese population. J Orthop Res 2012;30:9-14. [PMID: 21748790 DOI: 10.1002/jor.21494] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
7 Glas J, Wagner J, Seiderer J, Olszak T, Wetzke M, Beigel F, Tillack C, Stallhofer J, Friedrich M, Steib C. PTPN2 gene variants are associated with susceptibility to both Crohn’s disease and ulcerative colitis supporting a common genetic disease background. PLoS One. 2012;7:e33682. [PMID: 22457781 DOI: 10.1371/journal.pone.0033682] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
8 Fűri I, Sipos F, Germann TM, Kalmár A, Tulassay Z, Molnár B, Műzes G. Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects. World J Gastroenterol 2013;19:4119-26. [PMID: 23864774 DOI: 10.3748/wjg.v19.i26.4119] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
9 Vítek L. Bile acid malabsorption in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:476-483. [PMID: 25248001 DOI: 10.1097/mib.0000000000000193] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
10 Zhang M, Ni J, Xu W, Wen P, Qiu L, Wang X, Pan H, Ye D. Association of CTLA-4 variants with susceptibility to inflammatory bowel disease: A meta-analysis. Human Immunology 2014;75:227-33. [DOI: 10.1016/j.humimm.2013.12.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
11 Sezaki T, Inada K, Sogabe T, Kakuda K, Tomiyama L, Matsuno Y, Ichikawa T, Matsuo M, Ueda K, Kioka N. Role of Dlg5/lp-dlg, a membrane-associated guanylate kinase family protein, in epithelial-mesenchymal transition in LLc-PK1 renal epithelial cells. PLoS One 2012;7:e35519. [PMID: 22539977 DOI: 10.1371/journal.pone.0035519] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
12 Liu J, Liu YY, Liu J, Li BZ, Cen H, Xu WD, Leng RX, Pan HF, Ye DQ. Association between CARD8 rs2043211 polymorphism and inflammatory bowel disease: a meta-analysis. Immunol Invest 2015;44:253-64. [PMID: 25564880 DOI: 10.3109/08820139.2014.988721] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
13 Yang HY, Lu KC, Lee HS, Huang SM, Lin YF, Wu CC, Salter DM, Su SL. Role of the functional Toll-Like receptor-9 promoter polymorphism (-1237T/C) in increased risk of end-stage renal disease: a case-control study. PLoS One 2013;8:e58444. [PMID: 23472199 DOI: 10.1371/journal.pone.0058444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
14 Medrano LM, García-Magariños M, Dema B, Espino L, Maluenda C, Polanco I, Figueredo MÁ, Fernández-Arquero M, Núñez C. Th17-related genes and celiac disease susceptibility. PLoS One 2012;7:e31244. [PMID: 22359581 DOI: 10.1371/journal.pone.0031244] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
15 Obermeier F, Hofmann C, Falk W. Inflammatory bowel diseases: when natural friends turn into enemies-the importance of CpG motifs of bacterial DNA in intestinal homeostasis and chronic intestinal inflammation. Int J Inflam 2010;2010:641910. [PMID: 21188217 DOI: 10.4061/2010/641910] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
16 Wu MH, Zhang P, Huang X. Toll-like receptors in innate immunity and infectious diseases. Front Med China 2010;4:385-93. [PMID: 21136206 DOI: 10.1007/s11684-010-0600-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
17 Naser SA, Arce M, Khaja A, Fernandez M, Naser N, Elwasila S, Thanigachalam S. Role of ATG16L, NOD2 and IL23R in Crohn’s disease pathogenesis. World J Gastroenterol 2012; 18(5): 412-424 [PMID: 22346247 DOI: 10.3748/wjg.v18.i5.412] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 53] [Article Influence: 5.2] [Reference Citation Analysis]
18 Karody V, Reese S, Kumar N, Liedel J, Jarzembowski J, Sampath V. A toll-like receptor 9 (rs352140) variant is associated with placental inflammation in newborn infants. J Matern Fetal Neonatal Med. 2016;29:2210-2216. [PMID: 26371589 DOI: 10.3109/14767058.2015.1081590] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
19 Price AE, Shamardani K, Lugo KA, Deguine J, Roberts AW, Lee BL, Barton GM. A Map of Toll-like Receptor Expression in the Intestinal Epithelium Reveals Distinct Spatial, Cell Type-Specific, and Temporal Patterns. Immunity 2018;49:560-575.e6. [PMID: 30170812 DOI: 10.1016/j.immuni.2018.07.016] [Cited by in Crossref: 107] [Cited by in F6Publishing: 101] [Article Influence: 26.8] [Reference Citation Analysis]
20 Hradsky O, Dusatkova P, Lenicek M, Bronsky J, Nevoral J, Vitek L, Lukas M, Zeniskova I, Cinek O. The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease. BMC Med Genet 2010;11:91. [PMID: 20537165 DOI: 10.1186/1471-2350-11-91] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
21 Burgueño JF, Abreu MT. Epithelial Toll-like receptors and their role in gut homeostasis and disease. Nat Rev Gastroenterol Hepatol 2020;17:263-78. [DOI: 10.1038/s41575-019-0261-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 26.5] [Reference Citation Analysis]
22 Morgan AR, Lam WJ, Han DY, Fraser AG, Ferguson LR. Genetic variation within TLR10 is associated with Crohn's disease in a New Zealand population. Hum Immunol 2012;73:416-20. [PMID: 22342453 DOI: 10.1016/j.humimm.2012.01.015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
23 Álvarez-rodríguez L, López-hoyos M, Beares I, Calvo-alén J, Ruiz T, Villa I, Martínez-taboada V. Toll-like receptor 9 gene polymorphisms in polymyalgia rheumatica and giant cell arteritis. Scandinavian Journal of Rheumatology 2012;41:487-9. [DOI: 10.3109/03009742.2012.704392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Török HP, Bellon V, Konrad A, Lacher M, Tonenchi L, Siebeck M, Brand S, De Toni EN. Functional Toll-Like Receptor (TLR)2 polymorphisms in the susceptibility to inflammatory bowel disease. PLoS One 2017;12:e0175180. [PMID: 28388655 DOI: 10.1371/journal.pone.0175180] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
25 Dragasevic S, Stankovic B, Sokic-Milutinovic A, Milosavljevic T, Milovanovic T, Lukic S, Drazilov SS, Klaassen K, Kotur N, Pavlovic S, Popovic D. Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study. Clin Immunol 2018;197:86-95. [PMID: 30193869 DOI: 10.1016/j.clim.2018.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
26 Gutiérrez A, Zapater P, Juanola O, Sempere L, García M, Laveda R, Martínez A, Scharl M, González-navajas JM, Such J, Wiest R, Rogler G, Francés R. Gut Bacterial DNA Translocation is an Independent Risk Factor of Flare at Short Term in Patients With Crohn’s Disease. American Journal of Gastroenterology 2016;111:529-40. [DOI: 10.1038/ajg.2016.8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
27 Ray A, Dittel BN. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology 2015;146:359-68. [PMID: 26211540 DOI: 10.1111/imm.12511] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
28 Wehkamp J, Stange EF. Paneth's disease. J Crohns Colitis. 2010;4:523-531. [PMID: 21122555 DOI: 10.1016/j.crohns.2010.05.010] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 7.3] [Reference Citation Analysis]
29 Pimentel-Nunes P, Soares JB, Roncon-Albuquerque R, Dinis-Ribeiro M, Leite-Moreira AF. Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opin Ther Targets. 2010;14:347-368. [PMID: 20146632 DOI: 10.1517/14728221003642027] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
30 Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis. 2010;16:1583-1597. [PMID: 20803699 DOI: 10.1002/ibd.21282] [Cited by in Crossref: 222] [Cited by in F6Publishing: 211] [Article Influence: 18.5] [Reference Citation Analysis]
31 Skieceviciene J, Kiudelis G, Ellinghaus E, Balschun T, Jonaitis LV, Zvirbliene A, Denapiene G, Leja M, Pranculiene G, Kalibatas V, Saadati H, Ellinghaus D, Andersen V, Valantinas J, Irnius A, Derovs A, Tamelis A, Schreiber S, Kupcinskas L, Franke A. Replication Study of Ulcerative Colitis Risk Loci in a Lithuanian–Latvian Case–Control Sample: . Inflammatory Bowel Diseases 2013;19:2349-55. [DOI: 10.1097/mib.0b013e3182a3eaeb] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
32 Nasef NA, Ferguson LR. Inflammatory bowel disease and pregnancy: overlapping pathways. Transl Res. 2012;160:65-83. [PMID: 22687963 DOI: 10.1016/j.trsl.2011.12.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
33 Shang J, Wang X, Wang W, Pan H, Liu S, Li L, Chen L, Xia B. Association between Toll-Like Receptor 9-1237T/C Polymorphism and the Susceptibility of Inflammatory Bowel Diseases: A Meta-Analysis. Yonsei Med J 2016;57:153-64. [PMID: 26632396 DOI: 10.3349/ymj.2016.57.1.153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Petersen HJ, Smith AM. The role of the innate immune system in granulomatous disorders. Front Immunol 2013;4:120. [PMID: 23745122 DOI: 10.3389/fimmu.2013.00120] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
35 Gutiérrez A, Scharl M, Sempere L, Holler E, Zapater P, Almenta I, González-Navajas JM, Such J, Wiest R, Rogler G, Francés R. Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease. Gut 2014;63:272-80. [PMID: 23376290 DOI: 10.1136/gutjnl-2012-303557] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
36 Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol. 2011;8:152-168. [PMID: 21304476 DOI: 10.1038/nrgastro.2011.3] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 9.0] [Reference Citation Analysis]
37 Cheng JF, Ning YJ, Zhang W, Lu ZH, Lin L. T300A polymorphism of ATG16L1 and susceptibility to inflammatory bowel diseases: A meta-analysis. World J Gastroenterol 2010; 16(10): 1258-1266 [PMID: 20222171 DOI: 10.3748/wjg.v16.i10.1258] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
38 Peixoto-Rangel AL, Miller EN, Castellucci L, Jamieson SE, Peixe RG, Elias Lde S, Correa-Oliveira R, Bahia-Oliveira LM, Blackwell JM. Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9). Mem Inst Oswaldo Cruz 2009;104:1187-90. [PMID: 20140383 DOI: 10.1590/s0074-02762009000800019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
39 Wagener J, Malireddi RK, Lenardon MD, Köberle M, Vautier S, MacCallum DM, Biedermann T, Schaller M, Netea MG, Kanneganti TD, Brown GD, Brown AJ, Gow NA. Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation. PLoS Pathog 2014;10:e1004050. [PMID: 24722226 DOI: 10.1371/journal.ppat.1004050] [Cited by in Crossref: 170] [Cited by in F6Publishing: 163] [Article Influence: 21.3] [Reference Citation Analysis]
40 Sahingur SE, Xia XJ, Gunsolley J, Schenkein HA, Genco RJ, De Nardin E. Single nucleotide polymorphisms of pattern recognition receptors and chronic periodontitis. J Periodontal Res 2011;46:184-92. [PMID: 21118416 DOI: 10.1111/j.1600-0765.2010.01327.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
41 Messaritakis I, Stogiannitsi M, Koulouridi A, Sfakianaki M, Voutsina A, Sotiriou A, Athanasakis E, Xynos E, Mavroudis D, Tzardi M, Souglakos J. Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer. PLoS One. 2018;13:e0197327. [PMID: 29883450 DOI: 10.1371/journal.pone.0197327] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
42 Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol. 2011;8:152-168. [PMID: 21304476 DOI: 10.1038/nrgastro.2011.56.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Viet NH, Trung NQ, Dong LT, Trung LQ, Espinoza JL. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2021;147:713-23. [PMID: 33392659 DOI: 10.1007/s00432-020-03475-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Hotte NS, Salim SY, Tso RH, Albert EJ, Bach P, Walker J, Dieleman LA, Fedorak RN, Madsen KL. Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA. PLoS One. 2012;7:e37932. [PMID: 22649567 DOI: 10.1371/journal.pone.0037932] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
45 Eshleman EM, Alenghat T. Epithelial sensing of microbiota-derived signals. Genes Immun 2021. [PMID: 33824498 DOI: 10.1038/s41435-021-00124-w] [Reference Citation Analysis]
46 Berkowitz D, Peri R, Lavy A, Kessel A. Increased Toll-like receptor 9 expression by B cells from inflammatory bowel disease patients. Hum Immunol. 2013;74:1519-1523. [PMID: 24007656 DOI: 10.1016/j.humimm.2013.08.285] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
47 Berenson CS, Kruzel RL, Wrona CT, Mammen MJ, Sethi S. Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms. PLoS One 2015;10:e0134209. [PMID: 26361369 DOI: 10.1371/journal.pone.0134209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
48 Abad C, González-Escribano MF, Diaz-Gallo LM, Lucena-Soto JM, Márquez JL, Leo E, Crivell C, Gómez-García M, Martín J, Núñez-Roldán A, García-Lozano JR. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2. Genes Immun 2011;12:635-42. [PMID: 21716313 DOI: 10.1038/gene.2011.41] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
49 Polgar N, Csongei V, Szabo M, Zambo V, Melegh BI, Sumegi K, Nagy G, Tulassay Z, Melegh B. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease. Int J Immunogenet. 2012;39:247-252. [PMID: 22269120 DOI: 10.1111/j.1744-313x.2012.01084.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
50 Lange NE, Zhou X, Lasky-Su J, Himes BE, Lazarus R, Soto-Quirós M, Avila L, Celedón JC, Hawrylowicz CM, Raby BA, Litonjua AA. Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypes. BMC Med Genet 2011;12:26. [PMID: 21324137 DOI: 10.1186/1471-2350-12-26] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
51 Schaefer JS. MicroRNAs: how many in inflammatory bowel disease? Curr Opin Gastroenterol. 2016;32:258-266. [PMID: 27138057 DOI: 10.1097/mog.0000000000000284] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
52 Basso PJ, Fonseca MT, Bonfá G, Alves VB, Sales-Campos H, Nardini V, Cardoso CR. Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease. Braz J Med Biol Res 2014;47:727-37. [PMID: 25075576 DOI: 10.1590/1414-431x20143932] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]